Page 3,900«..1020..3,8993,9003,9013,902..3,9103,920..»

Army to begin gender treatment for secrets leaker Manning

Posted: Published on July 19th, 2014

WASHINGTON National security leaker Chelsea Manning can get initial treatment for a gender-identity condition from the U.S. military, after defense officials initially said the Army didn't have the medical expertise needed to give Manning the best treatment. Defense Secretary Chuck Hagel approved the Army's recommendation to keep the Army private in military custody and start a rudimentary level of gender treatment, a defense official said Thursday. The move follows the federal prisons bureau's rejection of the Army's request to accept her transfer from Fort Leavenworth, Kansas, to a civilian facility. Manning's treatment request was the first by a transgender military inmate, and it set up a dilemma for the Defense Department over how to treat a soldier for a diagnosed disorder without violating long-standing military policy. The initial gender treatments provided by the military could include allowing Manning to wear some female undergarments and also possibly provide some hormone treatments. The decision raises a number of questions about what level of treatment Manning will be able to get and at what point she would have to be transferred from the all-male prison to a female facility. In May, Manning's lawyer, David Coombs, had contended that civilian prisons were not as … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Army to begin gender treatment for secrets leaker Manning

Secrets leaker Manning to begin gender treatments

Posted: Published on July 19th, 2014

WASHINGTON National security leaker Chelsea Manning can get initial treatment for a gender-identity condition from the U.S. military, after defense officials initially said the Army didn't have the medical expertise needed to give Manning the best treatment. Defense Secretary Chuck Hagel approved the Army's recommendation to keep the Army private in military custody and start a rudimentary level of gender treatment, a defense official said Thursday. The move follows the federal prisons bureau's rejection of the Army's request to accept her transfer from Fort Leavenworth, Kansas, to a civilian facility. Manning's treatment request was the first by a transgender military inmate, and it set up a dilemma for the Defense Department over how to treat a soldier for a diagnosed disorder without violating long-standing military policy. The initial gender treatments provided by the military could include allowing Manning to wear some female undergarments and also possibly provide some hormone treatments. The decision raises a number of questions about what level of treatment Manning will be able to get and at what point she would have to be transferred from the all-male prison to a female facility. In May, Manning's lawyer, David Coombs, had contended that civilian prisons were not as … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Secrets leaker Manning to begin gender treatments

Testosterone therapy may pose cardiovascular risk to men: Health Canada

Posted: Published on July 19th, 2014

; FILE - In an Oct. 11, 2012, photograph, a basket of medical supplies await storage by King's Daughters Medical Center emergency room staff in Brookhaven, Miss. TORONTO Health Canada is warning consumers and health-care providers about a potential risk of serious and life-threatening cardiovascular problems linked to testosterone replacement therapy for men. Testosterone replacement products are used in men whose bodies dont make enough of the hormone, causing such effects as flagging libido, low energy, loss of muscle, mood swings and disturbed sleep. A recent Health Canada safety review found a growing body of evidence suggesting that the use of replacement testosterone may pose an increased risk of heart attack, stroke, blood clots in the lungs or legs, and heart rhythm irregularities. The federal department says testosterone replacement products should not be used in men for non-specific symptoms if lab tests have not confirmed a low testosterone level, nor should they be used in children under 18 nor in women. Men should advise their doctor of any history of cardiovascular disease or symptoms that might indicate such disease before using testosterone replacement therapy. The agency also says health providers should assess patients for cardiovascular disease risks before prescribing testosterone … Continue reading

Posted in Hormone Replacement Therapy | Comments Off on Testosterone therapy may pose cardiovascular risk to men: Health Canada

Lung Center justifies P70-M DAP fund, says went to 4 key departments besides stem cell research

Posted: Published on July 19th, 2014

InterAksyon.com The online news portal of TV5 MANILA - The Lung Center of the Philippines (LCP) has justified the P70-million allocation it received through the controversial Disbursement Acceleration Program (DAP) for stem cell research, saying that as the only tertiary pulmonary specialty hospital in the Philippines, it should take the lead, not only in cutting edge treatment but also in advocacies. The DAP-funded equipment dubbed by critics as untested and expensive were also used, according to LCP executive director Jose Luis Danguilan, for other purposes in four other key departments of the hospital. The specialty hospital based in Quezon City actually got P105 million through DAP in 2012 of which P70 million went to the Bio-regenerative Program and P35 million for the Pediatric Unit. To spend the money wisely, it was decided that pieces of equipment needed for the Bioregenerative Program and the Pediatric Unit could also be used by the Department of Pathology and Laboratory, the Department of Thoracic Surgery and Surgery, the Department of Pulmonary Medicine and the Department of Radiology, he added. Earlier, Philippine College of Physician president Anthony Leachon criticized the decision to allocate funds for stem cell therapy, describing it as an untested , expensive … Continue reading

Posted in Stem Cell Research | Comments Off on Lung Center justifies P70-M DAP fund, says went to 4 key departments besides stem cell research

Trendsetters at Work: Dr. Dana Khuthaila, Plastic Surgeon

Posted: Published on July 18th, 2014

In this crazy world of plastic surgery that we live in, we had to knowis it really as chaotic as it seems?! Luckily for us,Dr. Dana Khuthaila was able to set the record straight and give us an insider's look at her posh New York City office. As a celebrity surgeon to the stars (sorry, no Hollywood secrets being spilled here, people!) she knows a thing or two about making things perfect. Check out her exclusive interview with us to learn about how she came into her profession and why exactly she has breast implants currently sitting on her desk! What was your very first job? From as early as I can remember I was interested in medicine. My first job was as a volunteer at a hospital during the summertime. How did you get started in your career? I've always had an innate interest in medicine, and it was during my early internships that I realized it was more than an interest. Medicine is my passion. It was a difficult road to navigate since I was the first person in my family interested in a career in medicine, but I turned that passion into a career through hard work … Continue reading

Posted in Aesthetic Medicine | Comments Off on Trendsetters at Work: Dr. Dana Khuthaila, Plastic Surgeon

Case Study: Stem Cells vs Coronary Artery Bypass Surgery in a Patient with Multi-Vessel Disease 6 Year Follow Up

Posted: Published on July 18th, 2014

Case Study: Stem Cells vs Coronary Artery Bypass Surgery in a Patient with Multi-Vessel Disease 6 Year Follow Up Stem cells outperform heart bypass surgery. A heart patient treated with his own stem cells instead of undergoing coronary bypass surgery is exceeding all expectations 6 years after his adult stem cell treatment. In 2008, Howie Lindeman, then 58 years old, was facing open heart bypass surgery for three blocked coronary arteries. Lindeman, now 64, had his first heart attack at age 39 that severely damaged his heart. He went through multiple procedures over the last several years including having several stents placed in his blocked arteries. When he developed almost constant chest pain and struggled to walk just 25 feet his doctors decided to perform another heart catheterization. They found severe disease; two arteries were 100% blocked and the remaining one was at 80%. Cardiac bypass surgery was immediately recommended. Lindeman was not quite ready to have his chest cracked open, so he sought alternative options. He was aware of successful treatments for single blocked arteries with stem cells. Determined to avoid surgery he inquired as to the possibility of stem cell treatment for his condition. Dr. Zannos Grekos, a … Continue reading

Comments Off on Case Study: Stem Cells vs Coronary Artery Bypass Surgery in a Patient with Multi-Vessel Disease 6 Year Follow Up

Durham family of 11-year-old leukemia patient getting help with medical bills

Posted: Published on July 18th, 2014

DURHAM, N.C. - A lifesaving stem cell transplant for a little boy in Durham was a success but now the family of Nasir Holman is stuck with massive medical bills. The Holmans teamed up with a national non-profit to raise money for the treatment and to help other transplant patients. Duke Hospital has become a second home to Tameka Holman and 11-year-old Nasir. The young boy is battling leukemia for the second time in his short life. "He has been through so much and when you see him, he has a smile that will throw you back," said Tameka Holman. She said his treatment is going well, but it's been a long journey for his family. "It had got to one point, I prayed that it it would be taken from him and given it to me," she said. "But I had to accept that it's there and I have to roll with the punches." Doctors performed a stem cell transplant in April, but the family is having a hard time paying the medical bills. Doctors told the Holman family about the Children's Organ Transplant Association, also known as COTA. The nonprofit raises money for transplant related expenses. It hopes … Continue reading

Comments Off on Durham family of 11-year-old leukemia patient getting help with medical bills

DR ANDREW J ROCHMAN: ON STEM CELL THERAPY – Video

Posted: Published on July 18th, 2014

DR ANDREW J ROCHMAN: ON STEM CELL THERAPY By: Len Promoter … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on DR ANDREW J ROCHMAN: ON STEM CELL THERAPY – Video

Diabetes stem cell therapy readied

Posted: Published on July 18th, 2014

Paul Laikind, CEO of ViaCyte, which is making a treatment for diabetes from human embryonic stem cells. In an historic announcement for the stem cell field, San Diego's ViaCyte said Thursday it has applied to start human clinical trials of its treatment for Type 1 diabetes. ViaCyte grows replacement insulin-producing cells from human embryonic stem cells. The cells are packaged while maturing in a semi-permeable device and implanted. In animal trials, the cells produce insulin, relieving diabetes. Now the company proposes to take what could be a cure for diabetes into people. ViaCyte has asked to begin a Phase 1/2 clinical trial, which would assess both safety and efficacy of its product. ViaCyte is targeting Type 1 diabetes, in which the insulin-producing cells are destroyed. Patients require multiple injections of insulin daily to survive. The announcement is good news for California's stem cell agency, the California Institute for Regenerative Medicine. The agency has awarded nearly $39 million to ViaCyte to ready its device for human use. Paul Laikind, ViaCytes chief executive, said if all goes smoothly, the first patients will be treated in August or September. Based on animal studies, it will take a few months to see results, and … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Diabetes stem cell therapy readied

USC, UCLA and UCSF put their heads together to find cures for craniofacial defects

Posted: Published on July 18th, 2014

PUBLIC RELEASE DATE: 17-Jul-2014 Contact: Cristy Lytal lytal@med.usc.edu 323-442-2172 University of Southern California - Health Sciences One in every 2,000 babies is born with a skull that can't grow normally. Various sections of these babies' skulls are fused together at joints called sutures, constricting the developing brain and disrupting vision, sleep, eating and IQ. For these young patients, risky skull-expanding surgeries become an almost annual event. Now, three leading universities for stem cell research the University of Southern California (USC); the University of California, Los Angeles (UCLA); and the University of California, San Francisco (UCSF) have joined forces to find better solutions for these and other patients with craniofacial defects. All three institutions have leading stem cell research centers established with support from Eli and Edythe Broad, and all three are home to top scientists and clinicians in the field of craniofacial biology. "The value of this collaboration is bringing together a bunch of interested scientists from three major institutions in California around really important problems," said Andy McMahon, director of the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC. "It's really going to take a group of scientists across these different places with … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on USC, UCLA and UCSF put their heads together to find cures for craniofacial defects

Page 3,900«..1020..3,8993,9003,9013,902..3,9103,920..»